Literature DB >> 16200564

Prospective correction of affine motion for arbitrary MR sequences on a clinical scanner.

Kay Nehrke1, Peter Börnert.   

Abstract

The concept of prospective 3D affine motion correction was generalized, based on the Bloch equations, for signal excitation and sampling using arbitrary MR sequences. The technique was implemented on a clinical MRI scanner for Cartesian, radial, and spiral imaging sequences, as well as for 2D spatially selective RF excitation pulses. A patient-specific motion model steered by real-time navigators was employed to account for the additional degrees of freedom provided by the affine motion model. Different navigator concepts (multiple spatial and temporal navigators, quadratic navigators and other motion sensors) were investigated, with the aim of improving the correlation between navigator information and the motion model. Experiments on moving phantoms are presented to prove the technical feasibility of the approach. In vivo experiments on coronary MRA and renal MRI show the potential of the method for cardiac and abdominal applications hampered by respiratory motion. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16200564     DOI: 10.1002/mrm.20686

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  16 in total

1.  Homogeneous coordinates in motion correction.

Authors:  Benjamin Zahneisen; Thomas Ernst
Journal:  Magn Reson Med       Date:  2015-02-03       Impact factor: 4.668

Review 2.  Motion artifacts in MRI: A complex problem with many partial solutions.

Authors:  Maxim Zaitsev; Julian Maclaren; Michael Herbst
Journal:  J Magn Reson Imaging       Date:  2015-01-28       Impact factor: 4.813

3.  Patient specific prospective respiratory motion correction for efficient, free-breathing cardiovascular MRI.

Authors:  Michael A Bush; Rizwan Ahmad; Ning Jin; Yingmin Liu; Orlando P Simonetti
Journal:  Magn Reson Med       Date:  2019-02-14       Impact factor: 4.668

4.  Compressed-sensing motion compensation (CosMo): a joint prospective-retrospective respiratory navigator for coronary MRI.

Authors:  Mehdi H Moghari; Mehmet Akçakaya; Alan O'Connor; Tamer A Basha; Michele Casanova; Douglas Stanton; Lois Goepfert; Kraig V Kissinger; Beth Goddu; Michael L Chuang; Vahid Tarokh; Warren J Manning; Reza Nezafat
Journal:  Magn Reson Med       Date:  2011-06-10       Impact factor: 4.668

Review 5.  Prospective motion correction in functional MRI.

Authors:  Maxim Zaitsev; Burak Akin; Pierre LeVan; Benjamin R Knowles
Journal:  Neuroimage       Date:  2016-11-11       Impact factor: 6.556

6.  Utility of respiratory-navigator-rejected k-space lines for improved signal-to-noise ratio in three-dimensional cardiac MR.

Authors:  Mehmet Akçakaya; Jaime L Shaw; Thomas H Hauser; Reza Nezafat
Journal:  Magn Reson Med       Date:  2012-12-11       Impact factor: 4.668

7.  Subject-specific estimation of respiratory navigator tracking factor for free-breathing cardiovascular MR.

Authors:  Mehdi H Moghari; Peng Hu; Kraig V Kissinger; Beth Goddu; Lois Goepfert; Long Ngo; Warren J Manning; Reza Nezafat
Journal:  Magn Reson Med       Date:  2011-08-29       Impact factor: 4.668

Review 8.  Motion correction in MRI of the brain.

Authors:  F Godenschweger; U Kägebein; D Stucht; U Yarach; A Sciarra; R Yakupov; F Lüsebrink; P Schulze; O Speck
Journal:  Phys Med Biol       Date:  2016-02-11       Impact factor: 3.609

9.  Free-breathing 3D cardiac MRI using iterative image-based respiratory motion correction.

Authors:  Mehdi H Moghari; Sébastien Roujol; Raymond H Chan; Susie N Hong; Natalie Bello; Markus Henningsson; Long H Ngo; Beth Goddu; Lois Goepfert; Kraig V Kissinger; Warren J Manning; Reza Nezafat
Journal:  Magn Reson Med       Date:  2012-11-06       Impact factor: 4.668

10.  A respiratory self-gating technique with 3D-translation compensation for free-breathing whole-heart coronary MRA.

Authors:  Peng Lai; Xiaoming Bi; Renate Jerecic; Debiao Li
Journal:  Magn Reson Med       Date:  2009-09       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.